We are live on
!
Find out more
ACM
AlphaCrest Capital Management Portfolio holdings
AUM
$1.64B
1-Year Est. Return
23.4%
This Fund
S&P 500
This Quarter
Est. Return
-7.05%
1 Year Est. Return
-23.4%
3 Year Est. Return
-8.44%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.64B
AUM Growth
-$431M
(-21%)
Cap. Flow
-$291M
Cap. Flow
% of AUM
-17.73%
Top 10 Holdings %
Top 10 Hldgs %
4.35%
Holding
1,432
New
196
Increased
495
Reduced
565
Closed
176
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
American Tower
AMT
|
+$8.3M |
| 2 |
US Bancorp
USB
|
+$8.26M |
| 3 |
Sysco
SYY
|
+$5.67M |
| 4 |
Realty Income
O
|
+$5.32M |
| 5 |
Coca-Cola
KO
|
+$5.28M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Target
TGT
|
+$17.9M |
| 2 |
Electronic Arts
EA
|
+$14M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$11M |
| 4 |
JPMorgan Chase
JPM
|
+$10.9M |
| 5 |
Amgen
AMGN
|
+$10.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.02% |
| 2 | Financials | 16.14% |
| 3 | Healthcare | 13.06% |
| 4 | Industrials | 12.93% |
| 5 | Consumer Discretionary | 11.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BPMC
1051
DELISTED
Blueprint Medicines
BPMC
| $411K | 0.03% |
6,236
+1,353
| +28% | +$86.9K |
|
1052
Pacira BioSciences
PCRX
$1.04B
| $411K | 0.03% |
7,724
+1,093
| +16% | +$60.8K |
|
1053
Revolution Medicines
RVMD
$40B
| $408K | 0.02% |
+20,709
| New | +$455K |
|
1054
Travel + Leisure Co
TNL
$4.68B
| $408K | 0.02% |
11,970
-21,877
| -65% | -$925K |
|
1055
Sprouts Farmers Market
SFM
$7.23B
| $405K | 0.02% |
14,577
-12,064
| -45% | -$343K |
|
1056
New York Times
NYT
$11.7B
| $401K | 0.02% |
13,939
-17,157
| -55% | -$524K |
|
1057
Valvoline
VVV
$5.05B
| $400K | 0.02% |
15,789
+3,726
| +31% | +$109K |
|
1058
3D Systems Corp
DDD
$430M
| $399K | 0.02% |
50,056
+14,689
| +42% | +$151K |
|
1059
Lithia Motors
LAD
$7.88B
| $399K | 0.02% |
1,858
-1,506
| -45% | -$393K |
|
1060
Liberty Energy
LBRT
$2.75B
| $397K | 0.02% |
31,341
-16,566
| -35% | -$224K |
|
|
NVRO
1061
DELISTED
NEVRO CORP.
NVRO
| $394K | 0.02% |
+8,456
| New | +$392K |
|
1062
TC Energy
TRP
$71.2B
| $393K | 0.02% |
+9,758
| New | +$484K |
|
1063
Advanced Energy
AEIS
$11.7B
| $391K | 0.02% |
5,050
+935
| +23% | +$80.2K |
|
1064
Kulicke & Soffa
KLIC
$5.14B
| $390K | 0.02% |
10,127
-1,808
| -15% | -$80K |
|
1065
Frontdoor
FTDR
$5.1B
| $389K | 0.02% |
19,087
-89,251
| -82% | -$2.19M |
|
1066
Bank of Hawaii
BOH
$3.17B
| $388K | 0.02% |
5,098
+1,958
| +62% | +$154K |
|
1067
HubSpot
HUBS
$11.4B
| $388K | 0.02% |
1,436
-2,956
| -67% | -$939K |
|
1068
Molina Healthcare
MOH
$10.4B
| $388K | 0.02% |
1,176
-5,415
| -82% | -$1.74M |
|
1069
CNO Financial Group
CNO
$4.96B
| $387K | 0.02% |
21,515
-74,953
| -78% | -$1.39M |
|
1070
First Citizens BancShares
FCNCA
$24.3B
| $385K | 0.02% |
+483
| New | +$377K |
|
|
ETRN
1071
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $385K | 0.02% |
51,526
-76,553
| -60% | -$640K |
|
1072
10x Genomics
TXG
$5.83B
| $384K | 0.02% |
13,475
+6,603
| +96% | +$252K |
|
1073
GATX Corp
GATX
$6.52B
| $383K | 0.02% |
4,497
-8,377
| -65% | -$807K |
|
1074
Workiva
WK
$3.13B
| $378K | 0.02% |
4,862
-2,107
| -30% | -$144K |
|
1075
Hexcel
HXL
$8.28B
| $377K | 0.02% |
7,280
-10,278
| -59% | -$598K |
|
Similar funds
RHBC
BDF
SCA
IC
WFA
CA
RIG
CCP
AlphaCrest Capital Management's Q3 2022 Portfolio in Review
As of Q3 2022, AlphaCrest Capital Management held 1,432 positions worth $1.64B, down 21% from $2.07B the previous quarter. Its ten largest holdings account for 4.4% of the portfolio.
AlphaCrest Capital Management withdrew a net $291M in Q3 2022, closing 176 positions and reducing 565 holdings. Its most notable exit was Stryker, an estimated $7.96M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.
Against the trend, AlphaCrest Capital Management opened a new position in AT&T worth $3.27M.
- AlphaCrest Capital Management's largest Q3 2022 buy was AT&T: 212,810 shares worth $3.27M.
- AlphaCrest Capital Management added most to American Tower in Q3 2022, an estimated $8.3M increase.
- AlphaCrest Capital Management's biggest Q3 2022 reduction was Target, cutting an estimated $17.9M.
- AlphaCrest Capital Management fully exited Stryker in Q3 2022, selling an estimated $7.96M.
- AlphaCrest Capital Management's ten largest holdings make up 4.4% of its $1.64B portfolio in Q3 2022.
- AlphaCrest Capital Management opened 196 new positions and closed 176 in Q3 2022.
- AlphaCrest Capital Management's portfolio value fell 21% quarter-over-quarter to $1.64B.
Based on AlphaCrest Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.